Skip to main content

Advertisement

Table 2 Clinical factors and its association with LTFU

From: Predictors of loss to follow-up in art experienced patients in Nigeria: a 13 year review (2004–2017)

Maternal factors LTFU Total p (< 0.05)
No Yes
Regimen line at ART start
 Adult 1st line 140,977 (66.59) 70,719 (33.41) 211,696 (93.99) 0.003
 Adult 2nd line 1530 (67.08) 751 (32.92) 2281 (1.01)  
 Peadiatrics 1st line 7556 (68.24) 3516 (31.76) 11,071 (4.92)  
 Peadiatrics 2nd line 128 (69.95) 55 (30.05) 183 (0.08)  
Regimen line at end-point of study
 Adult 1st line 137,362 (66.26) 69,937 (33.74) 207,299 (92.04) < 0.001
 Adult 2nd line 6310 (73.75) 2246 (26.25) 8556 (3.80)  
 Adult 3rd line/others 8 (80.00) 2 (20.00) 10 (0.00)  
 Peadiatrics 1st Line 6265 (69.33) 2771 (30.67) 9036 (4.01)  
 Peadiatrics 2nd Line 246 (74.32) 85 (25.68) 331 (0.15)  
Months of ARV refill
 1 26,314 (50.63) 25,662 (49.37) 51,976 (23.08) < 0.001
 2 107,845 (73.53) 38,815 (26.47) 146,660 (65.12)  
 ≥ 3 16,032 (60.28) 10,554 (14.08) 26,596 (11.81)  
Duration on ART (month)
 ≤ 6 22,697 (40.57) 33,249 (59.43) 55,946 (24.84) < 0.001
 7–12 month 14,465 (67.08) 7098 (32.92) 21,563 (9.57)  
 13–24 21,199 (69.20) 9434 (30.80) 30,633 (13.60)  
 25+ 91,823 (78.43) 25,258 (21.57) 117,081 (51.98)  
Current viral load (c/ml)
 Undetected 41,251 (92.65) 3271 (7.36) 44,552 (19.77) < 0.001
 Detected 10,177 (82.55) 2152 (17.45) 12,329 (5.47)  
 None 98,763 (58.65) 69,618 (41.35) 168,381 (74.76)  
Current viral load (c/ml)
 Suppressed 27,751 (96.44) 1025 (3.56) 28,776 (12.78) < 0.001
 Unsuppressed 23,677 (84.33) 4398 (15.67) 28,075 (12.46)  
 None 98,763 (58.65) 69,618 (41.35) 168,381 (74.76)  
  1. p = p value which is in italics if significant at < 0.05